AI system
- System
-
Fujifilm AI endoscopy system on a Fujifilm 7000-series gastrointestinal endoscope (product name not given in the sources)
- Model
-
Not assessed
- Release
-
Not assessed
- Application developer
-
Fujifilm
- Role
-
Not assessed
- Configuration
-
Not assessed
- Inputs and outputs
-
Not assessed
- Autonomy
-
Not assessed
- Workflow
-
A positive fecal occult blood test in a free screening program, followed by colonoscopy. A Fujifilm AI system that marks suspicious polyps with a colored frame and a sound during the examination. Endoscopic removal and pathology at the same hospital.
- Human oversight
-
Not assessed
- Relation to AI
-
Taiwan Good News and Guan Chuan Media state that the AI system marked the suspicious polyp with a colored frame and sound during the examination. The physician then diagnosed and removed it. No source says the physician would have missed a 1 to 1.5 cm polyp in a patient already referred for a positive stool test. So the AI's share of this detection cannot be separated from the colonoscopy itself. All three reports relay the hospital's account. No clinical study of the system at this hospital was cited.
- AI contribution
-
Taiwan Good News and Guan Chuan Media state that the AI system marked the suspicious polyp with a colored frame and sound during the examination. The physician then diagnosed and removed it. No source says the physician would have missed a 1 to 1.5 cm polyp in a patient already referred for a positive stool test. So the AI's share of this detection cannot be separated from the colonoscopy itself. All three reports relay the hospital's account. No clinical study of the system at this hospital was cited.
Benefits
- Outcome identifiers
-
Not assessed
- Benefit
-
a 1 to 1.5 cm adenoma that biopsy confirmed as stage I colorectal cancer
- Category
-
Improved Physical Health
- Status
-
Not assessed
- Beneficiary groups
-
People.
- Beneficiaries
-
Not assessed
- Reach
-
Not assessed
- Distribution and access
-
Not assessed
- Duration
-
Not assessed
- Expected?
-
Yes
- Costs and harms
-
Not assessed
Measurement
- Studies
-
Not assessed
- Study design
-
Not assessed
- Measurement
-
Not assessed
- Setting and sample
-
Not assessed
- Measures
-
a 1 to 1.5 cm adenoma that biopsy confirmed as stage I colorectal cancer
- Comparison
-
Not assessed
- Results
-
a 1 to 1.5 cm adenoma that biopsy confirmed as stage I colorectal cancer
- Additional value from AI
-
Not assessed
- Limitations
-
Not assessed
- Denominators
-
Not assessed
- Materials for replication
-
Not assessed
Money
- Kind of value
-
Not assessed
- Amount
-
Not assessed
- Currency and prices
-
Not assessed
- Period and unit
-
Not assessed
- Realization
-
Not assessed
- Recipients and payers
-
Not assessed
- Gross or net
-
Not assessed
- Included costs
-
Not assessed
- Comparison
-
Not assessed
- Method
-
Not assessed
- Return and payback
-
Not assessed
People and places
- Participants
-
Developer: Fujifilm. Operator: St. Martin De Porres Hospital (天主教聖馬爾定醫院), Chiayi.
- Jurisdictions
-
Benefit: Chiayi,
Taiwan. Developer: 
Japan. Operator: Taiwan. - Ownership and control
-
Not assessed
- Dependencies
-
Not assessed
- Cross-border connections
-
Not assessed
- Geopolitical implications
-
Not assessed
Follow-up
- Conditions for replication
-
Patients attend screening and follow a positive stool test with colonoscopy. The endoscopist inspects and acts on the AI's marks. Bowel preparation adequate for the camera to see the mucosa.
- Replication attempts
-
Not assessed
- Later findings
-
Not assessed
- Availability
-
Not assessed
- Institutional decision
-
Not assessed
- Grounds
-
Not assessed
- Action and result
-
Not assessed
- Success criterion
-
Not assessed
Evidence
- Source numbers
-
AIBD-0370-source-0001–0004
- Citations
-
Numbered references below.
- Language
-
Not assessed
- Source relationships
-
Independent
- Original evidence
-
Not assessed
- Access and versions
-
Not assessed
- Supported findings
-
Not assessed
- Evidence links
-
Not assessed
- Evidence strength
-
Not assessed
- Missing evidence
-
Not assessed
Grades
- Assessed benefits
-
People.
- Depth
-
People: 3.
- Reasons
-
People: A stage I colorectal cancer inside a 1 to 1.5 cm adenoma was removed through the endoscope without surgery, per all three reports. A survival benefit is plausible for an early-stage cancer but is not demonstrated in the sources.
- Observed or intended
-
Not assessed
- Rubric
-
Not assessed
- Assessor and date
-
Not assessed
- Alternative assessments
-
Not assessed
- Fill
-
Independently reported
Entry details
- Kind
-
Not assessed
- Related entries
-
Not assessed
- Field
-
Healthcare - colorectal cancer screening. AI-assisted colonoscopy in hospital screening.
- Purpose
-
The Fujifilm AI system is built to mark suspicious polyps on the endoscopic image with a colored frame and sound. The physician then inspects and removes them. Flagging this adenoma was that function.
- Dates
-
Date basis unassessed: 2024 (precision unassessed). Updated: 21 October 2026.
- Stage
-
Not assessed
- Version
-
SHA-256: 68e1b533424b…
References
- Other identifiers
-
oecd_aim: 2024-04-19-de89.
- Category mappings
-
Not assessed
- Brief
-
Not assessed
- Revisions
-
4 revisions. Latest: 21 October 2026.
Sources
-
News report Independent author
丁偉杰 (2024). AI輔助醫師判讀瘜肉 大腸癌無所遁形. 自由健康網 (Liberty Times Net), 19 April 2024.
發現可疑瘜肉，經切片檢查證實為第一期大腸癌
-
News report Independent author
劉芳妃 (2024). 聖馬爾定醫院運用AI內視鏡檢查 大腸癌無所遁形. 台灣好報 via Yahoo奇摩新聞, 19 April 2024.
AI系統以色框標註並發出聲響，提示醫師可疑瘜肉
-
News report Independent author
吳東林 (2024). AI內視鏡檢查 大腸癌無所遁形. 觀傳媒 via Yahoo奇摩新聞, 19 April 2024.
診斷為1~1.5公分的腺瘤，經切片檢查證實為第一期大腸癌
-
Registry label Independent author
OECD AI Incidents and Hazards Monitor (2024). AI-Assisted Endoscopy Enables Early Detection and Removal of Colorectal Cancer. OECD.AI, 19 April 2024.
The AI system enabled early identification and removal of a cancerous polyp in a patient